证券代码：000809 证券简称：和展能源 公告编号：2025-034 辽宁和展能源集团股份有限公司 关于签订钢混塔筒销售合同暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 一、关联交易概述 2025 年 8 月 15 日，辽宁和展能源集团股份有限公司（以下简称"公司"） 召开第十二届董事会第十六次会议，审议通过了《关于签订钢混塔筒销售合同暨 关联交易的议案》，同意公司二级全资子公司辽宁昌和风电设备有限公司（以下 简称"昌和风电"）作为供方与采购方明阳智慧能源集团股份公司（以下简称"明 阳智能"）签订《铁岭昌图润荣 500MW项目 17 套钢-混凝土塔筒及附件采购合同》。 合同标的物为 17 套 7.5MW-233-160 型号钢-混凝土塔筒及附件，每套价格为 365 万元（含税），合同总金额为 6,205 万元（含税）。 本次明阳智能采购的钢混塔筒将应用于昌图润荣新能源有限公司（以下简称 "昌图润荣"）的 500MW风电项目，昌图润荣为公司董事长王海波先生间接控制 的企业，为公司的关联方，本次交易构成关联交易。 本次关联交易相关议案已于 2 ...

证券代码：000809 证券简称：和展能源 公告编号：2025-033 具体内容详见公司同日在巨潮资讯网（http://www.cninfo.com.cn）披露的 《关于签订钢混塔筒销售合同暨关联交易的公告》（公告编号：2025-034）。 辽宁和展能源集团股份有限公司 第十二届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 2025 年 8 月 11 日，辽宁和展能源集团股份有限公司（以下简称"公司"） 董事会以书面形式发出关于召开第十二届董事会第十六次会议的通知。本次会议 于 2025 年 8 月 15 日以现场和视频的方式在铁岭市凡河新区昆仑山路 42 号 38-1 号楼公司会议室召开，应出席董事 9 人，实际出席董事 9 人，会议由公司董事长 王海波先生主持。本次会议的召集、召开符合《中华人民共和国公司法》等有关 法律法规、部门规章、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 审议通过《关于签订钢混塔筒销售合同暨关联交易的议案》 公司二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和 ...

Core Viewpoint - The company has signed a procurement contract for wind power equipment, which is expected to generate significant revenue for the current fiscal year [1] Group 1: Contract Details - The company’s wholly-owned subsidiary, Liaoning Changhe Wind Power Equipment Co., Ltd., has entered into a contract with Mingyang Smart Energy Group Co., Ltd. for the procurement of 17 sets of steel-concrete towers and accessories for the Tieling Changtu Runrong 500MW project [1] - Each set of the 7.5MW-233-160 model steel-concrete tower is priced at 3.65 million yuan (including tax), leading to a total contract value of 62.05 million yuan (including tax) [1] Group 2: Financial Impact - The transaction is classified as a related party transaction and is anticipated to contribute over 50 million yuan in revenue to the company for the current year [1]

Group 1 - The company expects a loss for the first half of 2025, primarily due to delays in the delivery of mixed towers and the ongoing development of its new energy business, which has not yet generated revenue [4][5][6] - The company has produced 25 mixed tower products by June 30, 2025, with deliveries expected to begin in the third quarter [4] - Compared to the same period last year, the company's losses have decreased by 25.75% to 42.67%, attributed to the sale of a poorly performing subsidiary and investment income from idle funds [6][7] Group 2 - The company has provided a guarantee for its wholly-owned subsidiary, Changhe Wind Power Equipment Co., Ltd., for a credit line of up to RMB 80 million from Shanghai Pudong Development Bank [11] - The guarantee amount for a performance bond related to a wind power project is RMB 17.71 million, which is within the approved limit for guarantees [12][20] - As of the announcement date, the total amount of guarantees provided by the company and its subsidiaries is RMB 26.74 million, representing 0.98% of the latest audited net assets [21][22]

Performance Forecast - The company expects a net loss attributable to shareholders of 30.5 to 39.5 million yuan for the first half of 2025, compared to a loss of 53.2 million yuan in the same period of 2024 [1] - The net loss after deducting non-recurring gains and losses is projected to be between 33.5 to 42.5 million yuan, down from a loss of 53.21 million yuan in the previous year [1] - Basic earnings per share are estimated to be a loss of 0.037 to 0.048 yuan per share, compared to a loss of 0.064 yuan per share in the prior year [1] Reasons for Performance Change - The delay in the delivery of mixed tower equipment due to production conditions and buyer model adjustments has resulted in no expected sales revenue from mixed tower equipment, with revenue primarily coming from pre-stressed construction income [1] - The company produced 25 sets of mixed tower products by June 30, 2025, with deliveries expected to begin in the third quarter [1] - The new energy business is still in the development and approval stage, which has not yet generated revenue [1] Asset Disposal Impact - The company completed a significant asset sale of its subsidiary, reducing its stake to 38.68%, which has led to a decrease in losses from the previously underperforming land development business [2] - The company has also generated some investment income from idle funds [2] Disclosure and Reporting - The performance forecast is based on preliminary calculations by the company's finance department, with detailed financial data to be disclosed in the 2025 semi-annual report [2] - The company will adhere to legal and regulatory requirements for timely information disclosure [2]

证券代码：000809 证券简称：和展能源 公告编号：2025-032 辽宁和展能源集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 本次担保为公司对资产负债率超过 70%的全资子公司提供的担保，敬请投资 者关注担保风险。 一、担保情况概述 为满足业务发展需要，辽宁和展能源集团股份有限公司（以下简称"公司"） 二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和风电"）向上海浦 东发展银行股份有限公司铁岭分行（以下简称"浦发银行"）申请不超过人民币 8,000 万元授信。2025 年 6 月 30 日，公司与浦发银行签署《最高额保证合同》， 公司为昌和风电向浦发银行在 2025 年 6 月 25 日至 2026 年 6 月 24 日期间内办理 各类融资业务以本金余额最高不超过人民币 5,000 万元为限提供连带责任保证 担保，公司对债权发生期间内各单笔借款合同项下分期履行的还款义务承担保证 责任，保证期间为自每笔债权合同债务履行期届满之日起至该单笔合同最后一期 还款期限届满之日后三年。 2025 ...

[Current Period Performance Forecast](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company forecasts a net loss for the first half of 2025, with a significant reduction in the loss amount compared to the prior year [Performance Forecast](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company anticipates a net loss for H1 2025, with a significant reduction in the loss amount compared to the prior year, narrowing from **53.20 million yuan** to an estimated **30.50-39.50 million yuan** Performance Forecast Summary | Item | Current Period (Jan 1 - Jun 30, 2025) | Prior Period (Jan 1 - Jun 30, 2024) | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders of Listed Company** | Loss: 30.50 – 39.50 Million Yuan | Loss: 53.20 Million Yuan | | **Net Profit After Deducting Non-Recurring Gains and Losses** | Loss: 33.50 – 42.50 Million Yuan | Loss: 53.21 Million Yuan | | **Basic Earnings Per Share** | Loss: 0.037 – 0.048 Yuan/Share | Loss: 0.064 Yuan/Share | - The performance forecast indicates the company is in a loss-making state during the current reporting period[2](index=2&type=chunk) [Communication with Accounting Firm](index=1&type=section&id=Item%202.%20Communication%20with%20Accounting%20Firm) The company's performance forecast is a preliminary estimate and has not undergone pre-audit by a certified public accountant [Audit Status Explanation](index=1&type=section&id=Item%202.%20Communication%20with%20Accounting%20Firm) This performance forecast represents preliminary calculations by the company's finance department and has not been pre-audited by a certified public accountant - This performance forecast has not been pre-audited by a certified public accountant[3](index=3&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=Item%203.%20Explanation%20of%20Performance%20Changes) The company's loss is attributed to delayed project deliveries and nascent new energy operations, while the reduced loss is due to asset divestiture and investment income [Loss Cause Analysis](index=1&type=section&id=Item%203.1%20Loss%20Causes) The current period's loss is primarily due to delayed production and delivery in the hybrid tower equipment business, preventing revenue recognition, and the nascent stage of the new energy business which has not yet generated income - Delayed delivery of hybrid tower products due to project location in the north and buyer model adjustments resulted in no sales revenue from hybrid tower equipment in the current period, only prestressed construction income; **25 sets were produced in H1**, with deliveries expected to commence in Q3[4](index=4&type=chunk) - The company's new energy business remains in the development, approval, and construction phases, thus generating no revenue[4](index=4&type=chunk) [Year-over-Year Loss Reduction Analysis](index=1&type=section&id=Item%203.2%20Loss%20Reduction%20Causes) Compared to the prior year, the company's loss decreased by **25.75% to 42.67%**, primarily due to the divestiture of underperforming land primary development business and investment income from idle funds - The company divested significant assets of its controlled subsidiary, Tieling Caijing Investment Co., Ltd., at the end of 2024, reducing its stake to **38.68%** and thereby eliminating losses from the land primary development business accounted for by the equity method[4](index=4&type=chunk) - The company generated investment income from idle funds, contributing to the reduction in losses[5](index=5&type=chunk) [Other Relevant Information](index=2&type=section&id=Item%204.%20Other%20Relevant%20Information) The company reiterates that the performance forecast is preliminary and advises investors to consult official disclosures and exercise caution [Risk Warning and Information Disclosure](index=2&type=section&id=Item%204.%20Other%20Relevant%20Information) The company emphasizes that this performance forecast is a preliminary estimate, with final detailed financial data to be disclosed in the 2025 semi-annual report, and advises investors to monitor designated media and be aware of investment risks - This performance forecast is a preliminary calculation by the company's finance department, with final financial data subject to the 2025 semi-annual report[6](index=6&type=chunk) - The company's designated information disclosure media include China Securities Journal, Shanghai Securities News, Securities Daily, Securities Times, and Juchao Information Network, cautioning investors about investment risks[6](index=6&type=chunk)

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

Core Viewpoint - The successful signing of the mixed tower order reflects the client's recognition of the company's product reliability, economic efficiency, and customization capabilities, enhancing the company's market reputation in the wind power tower sector [1][2] Group 1: Contract Details - The contract signed between Changhe Company and Beijing Puhua Sunshine Investment Co., Ltd. involves the procurement of 54 sets of 160m steel-concrete towers for the Mudanjiang Linkou 300MW wind power project, with a total contract value of 177.12 million yuan (including tax) [1] - The delivery of the signed mixed tower order is expected to occur between October 2025 and December 2026, positively impacting the financial status and operational results for 2025 and 2026 [2] Group 2: Production and Supply Plans - Changhe Company will commence site construction, mold design, and production preparations immediately, with plans to complete material stocking by August 2025 and to fulfill 30 sets of production tasks by November 2025 [1][2] - The company aims to enhance its market expansion capabilities and industry competitiveness through this order, striving for better and faster development of its mixed tower business to improve revenue and profitability [2]

Overview - The company, Liaoning Hezhan Energy Group Co., Ltd., provides a guarantee for its wholly-owned subsidiary, Liaoning Changhe Wind Power Equipment Co., Ltd., to secure a loan from Shanghai Pudong Development Bank, with a maximum principal amount of RMB 50 million [1][2]. Guarantee Details - The guarantee is for a loan amount of RMB 9.0304 million, with a loan term from June 25, 2025, to June 24, 2026 [2]. - The total guarantee amount provided by the company for its subsidiaries in 2025 is capped at RMB 50 million, and this specific guarantee falls within that limit [2][4]. - After this guarantee, the company's total guarantee balance for Changhe Wind Power is RMB 9.0304 million, leaving a usable guarantee amount of RMB 40.9696 million [2]. Financial Situation of the Subsidiary - As of the end of March 2025, Changhe Wind Power's total assets were RMB 44.50832 million, with total liabilities of RMB 39.19745 million, resulting in a net asset value of RMB 5.31087 million [3]. - The asset-liability ratio for Changhe Wind Power was reported at 88.07% [3]. - The subsidiary's revenue for the first quarter of 2025 was RMB 0.8008 million, with a net loss of RMB 0.9724 million [3]. Contractual Obligations - The guarantee is a joint liability guarantee, meaning that if the subsidiary fails to meet its obligations, the company is liable for the debt without requiring other guarantees to be fulfilled first [4][5]. - The guarantee period extends three years beyond the maturity of each loan [5]. Board's Opinion - The board believes that providing this guarantee is essential for the operational needs of Changhe Wind Power and will not adversely affect the company's normal operations or the interests of shareholders, particularly minority shareholders [6]. Cumulative Guarantee Information - As of the announcement date, the total guarantee amount by the company and its subsidiaries is RMB 9.0304 million, which is 0.33% of the company's latest audited net assets [6]. - There are no overdue guarantees or guarantees involved in litigation as of the current date [6].